Quote:This is why the 350mg dose is working better than traditional receptor occupancy mathematics would predict. The standard calculation assumes each leronlimab molecule blocks exactly one CCR5 receptor on the cell surface. The clustering and internalization mechanism means each leronlimab binding event triggers a cascade that removes multiple receptors simultaneously from the CAML and CTC surface. The functional receptor occupancy achieved at 350mg is substantially higher than the dose-to-receptor ratio calculation suggests, because the drug is not merely occupying individual receptors. It is triggering a cellular reorganization that physically removes receptor clusters from the surface entirely.
Source: https://investorshangout.com/post/view?id=6834626
but back to ctDNA clearance. the fact that this acceptable and reliable test for ctDNA clearance is a blood test, and not an intrusive biopsy, means the science can move way faster and safer than ever before.
is ctDNA clearance a measurement of how well chemo is working? seems so.
https://oncodaily.com/oncolibrary/ctdna-clear...after-icis
will the medical establishment accept that ctDNA clearance is a measurement of how well leronlimab is working? they should...................................................................goose/gander
shouldnt leronlimab be approved for this function alone? there a chemo executive choking on a golf course somewhere today. his game is up. and he knows it.